The tariff classification of Lorazepam (CAS-846-49-1) imported in dosage/tablet form, from India
Issued March 7, 2008 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3004.90.9135
Headings: 3004
Product description
The subject product, Lorazepam in dosage/tablet form is a medicinal preparation containing Lorazepam, a benzodiazepine drug with CNS depressant, anxiolytic and sedative properties, as the active ingredient. It is indicated for the treatment of anxiety disorders and is also used conjunctively as an antiemetic in chemotherapy.
CBP rationale
The applicable subheading for the Lorazepam in dosage/tablet form, will be 3004.90.9135, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “"Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Antidepressants, tranquilizers, and other psychotherapeutic agents.
Full text
N023732 March 7, 2008 CLA-2-30:OT:RR:E:NC:N2:238 CATEGORY: Classification TARIFF NO.: 3004.90.9135 Mr. Colm Moynihan NorthStar Healthcare Limited 3300 Cork Airport Business Park Kinsale Road Cork, Ireland RE: The tariff classification of Lorazepam (CAS-846-49-1) imported in dosage/tablet form, from India Dear Mr. Moynihan: In your letter dated February 22, 2008, you requested a tariff classification ruling. The subject product, Lorazepam in dosage/tablet form is a medicinal preparation containing Lorazepam, a benzodiazepine drug with CNS depressant, anxiolytic and sedative properties, as the active ingredient. It is indicated for the treatment of anxiety disorders and is also used conjunctively as an antiemetic in chemotherapy. The applicable subheading for the Lorazepam in dosage/tablet form, will be 3004.90.9135, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “"Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Antidepressants, tranquilizers, and other psychotherapeutic agents." The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This product may be subject to the requirements of the Controlled Substances Act, which are enforced by the U.S. Drug Enforcement Administration (DEA), Office of Diversion Control. You may contact them at 2401 Jefferson Davis Highway, Alexandria, VA 22301, telephone (800) 882-9539. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Budesonide Capsules from India and Perphenazine Tablets from Italy
The tariff classification of Linezolid tablets and Trazodone Hydrochloride tablets in dosage form, from India
The tariff classification of Aripiprazole Orally Disintegrating Tablets in dosage form, from India
The tariff classification of Bupropion Hydrochloride Extended Release Tablets, imported in dosage form, from India. Correction to Ruling Number N258062.
The tariff classification of Bupropion Hydrochloride Extended Release Tablets, imported in dosage form, from India
The tariff classification of Olanzapine Tablets and Olanzapine Orally Disintegrating Tablets, imported in dosage form, from India
The tariff classification of Duloxetine Hydrochloride Capsules, imported in dosage form, from India
The tariff classification of Duloxetine Delayed Release Capsules, imported in dosage form, from India
The tariff classification of Bupropion Hydrochloride Extended Release Tablets, imported in dosage form, from India
The tariff classification of Duloxetine Hydrochloride Capsules (CAS-136434-34-9), imported in dosage form, from India
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →